Archives
-
o2h Ventures backed Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer
14 June, 2022
-
The “o2h human health KI EIS fund” makes an investment into Neurocentrx
12 May, 2022
-
The “o2h human health SEIS fund” makes an investment into Neucruit
18 February, 2022
-
o2h Ventures makes a follow-on investment into Oxford Drug Design
18 February, 2022
-
o2h Ventures makes an investment into Xploro from “the o2h human health SEIS fund”
16 February, 2022
-
In4Derm raises £1.6m pre-Series A funding to support its growing pipeline of first-in-class anti-inflammatory and orphan disease therapeutics
03 November, 2021
-
o2h Ventures “Human Health SEIS Fund” Invests into Sanome…
07 October, 2021
-
o2h Ventures portfolio company Small Pharma Successfully Completes Phase I Clinical Trial of DMT-assisted therapy
22 September, 2021
-
o2h Ventures backed Arecor enters into an exclusive formulation collaboration with Intas Pharmaceuticals
08 September, 2021